123 related articles for article (PubMed ID: 35025808)
1. Case of Adult Metastatic Medulloblastoma Demonstrated on 18F-DOPA PET/CT.
Marafi F; Sadeq A; Esmail A; Usmani S
Clin Nucl Med; 2022 Mar; 47(3):e318-e320. PubMed ID: 35025808
[TBL] [Abstract][Full Text] [Related]
2. (18)F-DOPA Positron Emission Tomography in Medulloblastoma: 2 Case Reports.
Cicone F; Clerico A; Minniti G; Paiano M; Carideo L; Scaringi C; Langen KJ; Scopinaro F
World Neurosurg; 2016 Sep; 93():490.e7-490.e11. PubMed ID: 27354292
[TBL] [Abstract][Full Text] [Related]
3. Metastatic Medulloblastoma: 18F-FDG and 68Ga-DOTANOC PET/CT in Response Evaluation.
ArunRaj ST; Kumar A; Kp H; Mohan N; Gupta S; Tripathi M; Bal C
Clin Nucl Med; 2021 May; 46(5):e262-e263. PubMed ID: 33315670
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. 68Ga-DOTANOC PET/CT in Medulloblastoma.
Arunraj ST; Parida GK; Damle NA; Arora S; Reddy S; Chakraborty D; Prabhu M; Tripathi M; Bal C
Clin Nucl Med; 2018 May; 43(5):e145-e146. PubMed ID: 29485447
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT.
Calabria F; Chiaravalloti A; Di Pietro B; Grasso C; Schillaci O
Nucl Med Commun; 2012 Jun; 33(6):563-70. PubMed ID: 22395034
[TBL] [Abstract][Full Text] [Related]
7. Adult Medulloblastoma Depicted With 99mTc-HYNIC-[D-Phe1, Tyr3-Octreotide] SPECT/CT.
Spyridonidis T; Papathanasiou N; Spiliotopoulou M; Papadimitropoulos C; Apostolopoulos DJ
Clin Nucl Med; 2020 Dec; 45(12):1001-1002. PubMed ID: 33086272
[TBL] [Abstract][Full Text] [Related]
8. Incidental Finding of Cerebellar Medulloblastoma on 68Ga-DOTATATE PET/CT in a Patient With Appendiceal Carcinoid.
Chan M; Hsiao E
Clin Nucl Med; 2016 Nov; 41(11):886-887. PubMed ID: 27607158
[TBL] [Abstract][Full Text] [Related]
9. [F-DOPA PET/MR based target definiton in the 3D based radiotherapy treatment of glioblastoma multiforme patients. First Hungarian experiences].
Sipos D; Tóth Z; Lukács G; Bajzik G; Hadjiev J; Cselik Z; Repa I; Kovács Á
Ideggyogy Sz; 2019 May; 72(5-6):209-215. PubMed ID: 31241266
[TBL] [Abstract][Full Text] [Related]
10. Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience.
Evangelista L; Cuppari L; Bellu L; Bertin D; Caccese M; Reccia P; Zagonel V; Lombardi G
Curr Radiopharm; 2019; 12(3):220-228. PubMed ID: 30644351
[TBL] [Abstract][Full Text] [Related]
11. In Reply to the Letter to the Editor Regarding "
Cicone F; Langen KJ; Minniti G
World Neurosurg; 2021 Jun; 150():255. PubMed ID: 34098660
[No Abstract] [Full Text] [Related]
12. In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment.
Holthoff VA; Herholz K; Berthold F; Widemann B; Schröder R; Neubauer I; Heiss WD
Cancer; 1993 Aug; 72(4):1394-403. PubMed ID: 8339230
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
Lapa C; Linsenmann T; Monoranu CM; Samnick S; Buck AK; Bluemel C; Czernin J; Kessler AF; Homola GA; Ernestus RI; Löhr M; Herrmann K
J Nucl Med; 2014 Oct; 55(10):1611-6. PubMed ID: 25125481
[TBL] [Abstract][Full Text] [Related]
14. Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid.
Caobelli F; Chiaravalloti A; Evangelista L; Saladini G; Schillaci O; Vadrucci M; Scalorbi F; Donner D; Alongi P;
Ann Nucl Med; 2018 Jan; 32(1):7-15. PubMed ID: 28986764
[TBL] [Abstract][Full Text] [Related]
15. Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
Kauhanen S; Seppänen M; Minn H; Gullichsen R; Salonen A; Alanen K; Parkkola R; Solin O; Bergman J; Sane T; Salmi J; Välimäki M; Nuutila P
J Clin Endocrinol Metab; 2007 Apr; 92(4):1237-44. PubMed ID: 17227804
[TBL] [Abstract][Full Text] [Related]
16.
Humbert O; Bourg V; Mondot L; Gal J; Bondiau PY; Fontaine D; Saada-Bouzid E; Paquet M; Chardin D; Almairac F; Vandenbos F; Darcourt J
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):558-568. PubMed ID: 30612162
[TBL] [Abstract][Full Text] [Related]
17. Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspective.
Walter F; Cloughesy T; Walter MA; Lai A; Nghiemphu P; Wagle N; Fueger B; Satyamurthy N; Phelps ME; Czernin J
J Nucl Med; 2012 Mar; 53(3):393-8. PubMed ID: 22323780
[TBL] [Abstract][Full Text] [Related]
18. Letter to the Editor Regarding "
Filippi L; Bagni O; Spinelli GP
World Neurosurg; 2021 Jun; 150():253-254. PubMed ID: 34098659
[No Abstract] [Full Text] [Related]
19. Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.
Pafundi DH; Laack NN; Youland RS; Parney IF; Lowe VJ; Giannini C; Kemp BJ; Grams MP; Morris JM; Hoover JM; Hu LS; Sarkaria JN; Brinkmann DH
Neuro Oncol; 2013 Aug; 15(8):1058-67. PubMed ID: 23460322
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
Rufini V; Treglia G; Castaldi P; Perotti G; Calcagni ML; Corsello SM; Galli G; Fanti S; Giordano A
Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
